Account
Consumer savings expert Andrea Woroch's top tips
FBN's Charlie Gasparino on SAC saying it will manage its own money if outsiders pull cash.
null
Concerned about the need to fight antibiotic resistance and possible bioterrorist attacks, the U.S. government will give drug maker GlaxoSmithKline PLC (GSK, GSK.LN)...
Stossel looks at affordable medical care offered by an Oklahoma doctor, guests debate the merits of ObamaCare and a veterinarian fights to keep his online consultations active
Stossel holds a 'real or fake' contest about taxes, exposes hidden fees and looks at an IRS parody video
WebMD Health Corp.'s (WBMD) first-quarter loss narrowed as the health-information provider posted revenue growth and lower expenses and also said its chief executive...
Eli Lilly & Co. (LLY) Chairman and Chief Executive John C. Lechleiter is scheduled to undergo surgery next week for a dilated aorta and is expected to make a full re...
Stossel looks at crony capitalism and monopolies that government picks as the 'chosen' ones
Dr. Marc Siegel on the suit against Novartis and whether doctors are being bribed by major pharmaceutical companies.
U.S. federal prosecutors filed a lawsuit against Novartis Pharmaceuticals, accusing the company of paying kickbacks to doctors in an effort to encourage prescription...
Federal prosecutors accused Novartis Pharmaceuticals Corp. of paying kickbacks and providing lavish dinners to doctors to encourage them to prescribe the company's b...
Biotechnology stocks are quite healthy right now, but some think they are due for a cold.The sector is on a run not seen since the go-go days of the late 1990s, bols...
Pharmaceutical companies need to boost the benefits of drug research by working with regulators and healthcare providers to overhaul the way medicines are approved a...
The U.S. Supreme Court ruled on Monday that the Federal Trade Commission can challenge deals brand-name drug companies make with generic rivals that keep cheaper pro...
Companies can't take charge of human body
Royalty Pharma, pursuing a hostile $8 billion takeover of Irish drugmaker Elan Corp Plc, moved on Tuesday to make sure it is not blocked by a potential $200 million ...
Health law is struggling to survive
New medical procedure uses radio frequency
U.S.-based investment firm Royalty Pharma is unable to go ahead with its hostile $6.4 billion bid for Irish drug firm Elan for now, following a New York court ruling...
